Skip to main content
. 2023 Sep 12;28(18):6586. doi: 10.3390/molecules28186586

Table 2.

Determination of inhibitory concentration (IC50) for Compounds 21, 24, 28–30 against Epidermal Growth Factor Receptor (EGFR) and BRAFV600E oncogene.

Compd. EGFR Inhibition
IC50 ± SEM (nM)
BRAFV600E Inhibition
IC50 ± SEM (nM)
21 72 ± 5 73 ± 6
24 73 ± 5 77 ± 6
28 70 ± 5 69 ± 6
29 75 ± 5 80 ± 7
30 68 ± 4 65 ± 5
Erlotinib 80 ± 5 ± 5